Unknown NA INTERVENTIONAL 1-arm NCT05433376

SOLSTICE Trial in China

Clinical Trial of the ShOckwave Coronary Intravascular Lithotripsy (IVL) System Used to Treat CalcIfied Coronary ArtEries (SOLSTICE)

Sponsor: Genesis Medtech Corporation

Conditions Calcifications Vascular Coronary Artery Disease

Interventions Shockwave Coronary Intravascular Lithotripsy (IVL) System C2

Updated 3 times since 2022 Last updated: Jun 21, 2022 Started: Apr 15, 2021 Primary completion: Nov 25, 2021 Completion: Nov 26, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Calcifications Vascular and Coronary Artery Disease, this trial is ongoing. The trial is conducted by Genesis Medtech Corporation and has accumulated 3 data snapshots since 2021. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Active Not Recruiting → Unknown
Jul 2022 — Jul 2024 [monthly]

Active Not Recruiting NA

First recorded

Apr 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Genesis Medtech Corporation

Data source: Genesis Medtech Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China